# A Phase 1 Study of CG001419 Administered Orally in Healthy Subjects

> **NCT06636500** · PHASE1 · COMPLETED · sponsor: **Cullgen Australia Pty Ltd** · enrollment: 72 (actual)

## Conditions studied

- Healthy Volunteer Study
- Pain Management

## Interventions

- **DRUG:** CG001419
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06636500
- **Lead sponsor:** Cullgen Australia Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-22
- **Primary completion:** 2025-12-05
- **Final completion:** 2025-12-05
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06636500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06636500, "A Phase 1 Study of CG001419 Administered Orally in Healthy Subjects". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06636500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*